CATALAYER NEWS
FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings - Fierce Biotech
Source: Fierce Biotech · 2026-03-17
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets